Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Synthesis and Cytocompatibility of Biodegradable Poly (L-Lactide-r-5-hydroxyl Trimethylene Carbonate) Copolymer

Synthesis, characterization and biocompatibility of novel biodegradable poly[((R)-3-hydroxybutyrate)-block-(D,L-lactide)-block-(ɛ-caprolactone)] triblock copolymers

Haemo- and cytocompatibility of bioresorbable homo- and copolymers prepared from 1,3-trimethylene carbonate, lactides, and ε-caprolactone

In Vivo Study on the Histocompatibility and Degradation Behavior of Biodegradable Poly(Trimethylene Carbonate-Co-D,L-Lactide)

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

In Vitro Biocompatibility Evaluation of Bioresorbable Copolymers Prepared from L-Lactide, 1, 3-Trimethylene Carbonate, and Glycolide for Cardiovascular Applications

Structure, Properties, and in Vitro Degradation Behavior of Biodegradable Poly(l‐lactic Acid)‐trimethylene Carbonate‐glycolide Terpolymer

Enhancement of the crystallization and biocompatibility of poly(TMC-b-(LLA-ran-GA)) by poly(lactide) stereocomplex

Biodegradable comb-dendritic tri-block copolymers consisting of poly(ethylene glycol) and poly(l-lactide): Synthesis, characterizations, and regulation of surface morphology and cell responses

Surface modification of poly(propylene carbonate) by aminolysis and layer-by-layer assembly for enhanced cytocompatibility.

Synthesis and Characterization of Amphiphilic Block Copolymer of Polyphosphoester and Poly(L-Lactic Acid)

Effect of surface treatment on the biocompatibility of microbial polyhydroxyalkanoates.

Lipid-like Diblock Copolymer As an Additive for Improving the Blood Compatibility of Poly(lactide-co-glycolide)

Cellular Compatibility of the Novel Modified Poly (L-Lactic Acid)

Enhancement of the crystallization and biocompatibility of poly(TMC-<i>b</i>-(LLA-<i>ran</i>-GA)) by poly(lactide) stereocomplex

Enhancement of crystallization and adjustment properties for biocompatible poly(lactide)-based thermoplastic polyurethane via stereocomplexation

Syntheses and properties of tri- and multi-block copolymers consisting of polybutadiene and polylactide segments

Enhancing Crystallization Behavior for Optimized Performances of Poly(tmc‐b‐(lla‐ran‐ga)) by PDLA/PLLA Stereocomplex Crystallization

Biocompatibility of Fully Biodegradable Polylactic Acid and Its Copolymers: Present and Future Applications

Novel Amphiphilic Block Copolymers Enhancing Osteoblast Attachment and Growth

Preparation and characterization of biomorphic poly(l-lactide-co-β-malic acid) scaffolds